Global Panic Disorders Market Insights Forecasts to 2033

• The Global Panic Disorders Market Size was Valued at USD 9.71 Billion in 2023
• The Market Size is Growing at a CAGR of 4.73% from 2023 to 2033
• The Worldwide Panic Disorders Market Size is Expected to Reach USD 15.42 Billion by 2033
• Asia Pacific is Expected to Grow the fastest during the forecast period.

The Global Panic Disorders Market Size is Anticipated to Exceed USD 15.42 Billion by 2033, Growing at a CAGR of 4.73% from 2023 to 2033.

Market Overview

Panic attacks occur frequently and without indication in people with panic disorder. Even in situations when there doesn't appear to be an obvious risk or cause, these attacks are characterized by an unexpected wave of panic, discomfort, or a feeling of losing control. Not every person who has a panic episode goes on to have panic disorder. Panic disorders frequently commence in the late teens or early adulthood. Panic disorder is more common in women than in men. The signs and symptoms of panic disorders generally include a sense of impending doom or danger, sweating, chills, nausea, chest pain, fast heart rate, headache, and numbness or tingling sensation. There are several causes for panic disorder, such as genetics, a character that is more prone to negative feelings or stress, major stress, and definite changes in the way parts of the brain function. Psychotherapy (often referred to as talk therapy), medicine (antidepressants, beta-blockers, and anti-anxiety), or a combination of the two are usually utilized to treat panic disorder. Some of the factors boosting the market are the prevalence of panic disorders, advancements in diagnostic technologies, and our growing awareness of the underlying neurobiological causes. The healthcare industry's market dynamics are significantly influenced by industry collaborations, regulatory clearances, and research and development initiatives. The market for panic disorders stands out due to its commitment to enhancing patient outcomes and standard of living. Looking for novel therapeutic targets and inventive treatment modalities is the aim of continuing research.

Report Coverage

This research report categorizes the market for the global panic disorders market based on various segments and regions forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global panic disorders market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global panic disorders market.

Driving Factors

The growing awareness about the disorders, the rising cases of mental and anxiety disorders, and the accessibility of effective treatment choices are some of the major factors that are predicted to drive the growth of panic disorders. Furthermore, the expansion of the market can be accelerated by the major companies' increased initiatives to increase understanding among customers. In recent years, numerous drugs have been in various phases of clinical trials, which may market rapidly thus propelling market growth. Moreover, the market for treatments of panic disorders will expand as a result of the introduction of new choices such as medicine, cognitive behavioral therapy, and relaxation methods. The field's ongoing technological advancements and research produce more customized and successful treatment options, which grow the market. Additionally, the market for treatments for panic disorders has an abundance of potential with the increased focus on focused therapy and personalized medicine. Improved patient results and efficacy can result from individualized therapy plans that are based on each patient's genetic profile, underlying causes, and unique symptoms.

Restraining Factors

The stigma related to mental health conditions, such as panic disorders, remains a remarkable barrier to market growth. The expansion of the healthcare sector is hampered by cultural barriers, discrimination, and misconceptions that frequently keep people from receiving timely medical care and diagnosis. In addition, a key barrier to the market for panic disorders is the absence of availability of mental healthcare services, especially in underserved or low-income areas. The diagnosis and treatment of panic disorders can be hindered by a lack of mental health specialists, a weak infrastructure, and financial obstacles, which might hamper the market's overall growth.

Market Segmentation

The global panic disorders market share is classified into treatment type, dosage form, and end-user.

• The medication segment is anticipated to hold the largest share of the global panic disorders market during the forecast period.    

On the basis of the treatment type, the global panic disorders market is divided into psychotherapy, medication, and others. Among these, the medication segment is anticipated to hold the largest share of the global panic disorders market during the forecast period. Panic disorder medications include serotonin & norepinephrine reuptake inhibitors (SNRIs), benzodiazepines, and others that deliver relief in depression symptoms, such as irritability, sadness, and others. Thus, owing to the above advantages of medication, the acquisition of panic disorder medication is increasing to lessen the cases of panic disorders. This factor is driving the expansion of the segment.

• The tablets segment is anticipated to hold the highest share of the global panic disorders market during the forecast period.

On the basis of the dosage form, the global panic disorders market is divided into tablets, injections, and others. Among these, the tablets segment is anticipated to hold the highest share of the global panic disorders market during the forecast period. The main benefits of a tablet form of panic disorder, involve high accuracy, unit dose, lower variability, and others. Additionally, tablets for panic disorder are easier to swallow, and in a few cases, they can easily dissolve in water for alimentation the pediatric patient. Thus, the above advantages regarding the tablets are propelling the positioning of tablets in panic disorder medication to confirm the decrease of anxiety, which in turn, is driving the tablet segment market expansion.

• The hospitals & clinics segment is anticipated to hold the highest share of the global panic disorders market during the forecast period.

On the basis of the end-user, the global panic disorders market is divided into hospitals & clinics and mental healthcare centers. Among these, the hospitals & clinics segment is anticipated to hold the highest share of the global panic disorders market during the forecast period. The application of panic disorder treatment, like medications and psychotherapy is growing in hospitals & clinics to reduce the occurrence and strength of panic disorders and improve the functions in daily life. One of the top clinics in Australia for treating panic disorders is NBMLHD-Anxiety Disorders Clinic, which serves as an affiliate of Nepean Blue Mountains LHD. Medication is used in this clinic to treat panic disorder. Therefore, the rising acquisition of panic disorder treatments in hospitals is advancing the expansion of the market.

Regional Segment Analysis of the Global Panic Disorders Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global panic disorders market over the predicted timeframe.

North America is anticipated to hold the largest share of the global panic disorders market over the predicted timeframe. There are several factors contributing to this region's rapid expansion, such as the abundance of participants in the industry and growing consumer knowledge of the availability of effective treatments for panic disorders. Furthermore, key factors that support the growing use of treatments for panic disorders to prevent panic disorders include the establishment of new healthcare facilities dedicated to treating panic disorders, partnerships between manufacturers of medications for treating panic disorders, clinical trials associated with the treatment of panic disorders to receive FDA approval and others. The United States is predicted to dominate the market and maintain this position of leadership during the projected period in North America. The main drivers of the region's dominance are the accessibility of treatment alternatives and the development in healthcare prices, both of which accelerate the revenue growth of the region's market.

Asia-Pacific is anticipated to grow at the fastest rate in the global panic disorders market over the predicted timeframe. This region is growing rapidly due to the major players' untapped tremendous opportunities. Furthermore, the growing spending power of consumers in the area is anticipated to fuel market expansion. Additional factors that are predicted to contribute to the revenue of market expansion during the predicted timeframe, involve the presence of generic manufacturing industries and the growth of the healthcare facilities in the Asia Pacific region. Moreover, with a notable increase in overall population in countries, like India and China, Asia Pacific is expected to experience a substantial revenue CAGR over the predicted timeframe.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global panic disorders market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Boehringer Ingelheim GmbH.
• F. Hoffmann-La Roche Ltd.
• Pfizer, Inc.
• Actavis Plc.
• Eli Lilly and Company
• Mylan, Inc.
• Bristol-Myers Squibb Company
• GlaxoSmithKline Plc.
• Valeant Pharmaceuticals International, Inc.
• H. Lundbeck A/S
• Sanofi
• Neurocrine Biosciences, Inc.
• AstraZeneca Plc.
• Bausch Health Companies Inc.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting And Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In July 2022, Cybin acquired Phase I N, N-dimethyltryptamine (DMT) study, a study for anxiety disorder treatment from Entheon Biomedical. The acquisition of the study is projected to boost the clinical development pathway of CYB004.

• In March 2021, the efficacy of Xenon Inhalation as a treatment for panic disorder was examined in two phase II and phase III trials that were double-blind, randomized, and placebo-controlled. The results show that xenon is a potentially effective treatment for panic disorder and that, even after the active phase of therapy, its anti-panic benefits last for a minimum of half a year.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the global panic disorders market based on the below-mentioned segments: 

Global Panic Disorders Market, By Treatment Type

• Psychotherapy
• Medication
• Others

Global Panic Disorders Market, By Dosage Form

• Tablets
• Injections
• Others

Global Panic Disorders Market, By End-User

• Hospitals & Clinics
• Mental Healthcare Centers

Global Panic Disorders Market, By Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • Uk
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa